Oriola-KD Oyj A (OKDAV) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.229x

Based on the latest financial reports, Oriola-KD Oyj A (OKDAV) has a cash flow conversion efficiency ratio of 0.229x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€30.40 Million ≈ $35.54 Million USD) by net assets (€132.60 Million ≈ $155.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Oriola-KD Oyj A (OKDAV) net asset quality to measure how much of total assets are equity-financed.

Oriola-KD Oyj A - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Oriola-KD Oyj A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Oriola-KD Oyj A's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Oriola-KD Oyj A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oriola-KD Oyj A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kayseri Seker Fabrikasi AS
IS:KAYSE
0.171x
Alithya Group inc Class A
TO:ALYA
0.010x
Alpha Pro Tech Ltd
NYSE MKT:APT
0.000x
Softtech Engineers Limited
NSE:SOFTTECH
0.042x
Llorente & Cuenca S.A.
MC:LLYC
0.283x
Rayence Co. Ltd
KQ:228850
0.022x
Welltend Technology Corp
TW:3021
0.056x
Minda Global Bhd
KLSE:5166
0.012x

Annual Cash Flow Conversion Efficiency for Oriola-KD Oyj A (2006–2024)

The table below shows the annual cash flow conversion efficiency of Oriola-KD Oyj A from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Oriola-KD Oyj A.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €133.40 Million
≈ $155.96 Million
€38.70 Million
≈ $45.24 Million
0.290x +417.66%
2023-12-31 €171.30 Million
≈ $200.27 Million
€9.60 Million
≈ $11.22 Million
0.056x -83.77%
2022-12-31 €225.60 Million
≈ $263.75 Million
€77.90 Million
≈ $91.07 Million
0.345x +87.15%
2021-12-31 €216.80 Million
≈ $253.46 Million
€40.00 Million
≈ $46.76 Million
0.185x -46.33%
2020-12-31 €169.60 Million
≈ $198.28 Million
€58.30 Million
≈ $68.16 Million
0.344x -35.97%
2019-12-31 €157.20 Million
≈ $183.78 Million
€84.40 Million
≈ $98.67 Million
0.537x -5.21%
2018-12-31 €181.50 Million
≈ $212.19 Million
€102.80 Million
≈ $120.18 Million
0.566x +372.47%
2017-12-31 €197.70 Million
≈ $231.13 Million
€23.70 Million
≈ $27.71 Million
0.120x -38.66%
2016-12-31 €205.20 Million
≈ $239.90 Million
€40.10 Million
≈ $46.88 Million
0.195x -55.57%
2015-12-31 €194.60 Million
≈ $227.51 Million
€85.60 Million
≈ $100.08 Million
0.440x +562.69%
2014-12-31 €113.60 Million
≈ $132.81 Million
€-10.80 Million
≈ $-12.63 Million
-0.095x -188.72%
2013-12-31 €278.10 Million
≈ $325.13 Million
€29.80 Million
≈ $34.84 Million
0.107x -26.80%
2012-12-31 €314.90 Million
≈ $368.15 Million
€46.10 Million
≈ $53.90 Million
0.146x +55.93%
2011-12-31 €299.30 Million
≈ $349.91 Million
€28.10 Million
≈ $32.85 Million
0.094x -62.67%
2010-12-31 €352.70 Million
≈ $412.34 Million
€88.70 Million
≈ $103.70 Million
0.251x -33.95%
2009-12-31 €265.00 Million
≈ $309.81 Million
€100.90 Million
≈ $117.96 Million
0.381x +490.22%
2008-12-31 €185.50 Million
≈ $216.87 Million
€-18.10 Million
≈ $-21.16 Million
-0.098x -150.94%
2007-12-31 €203.60 Million
≈ $238.03 Million
€39.00 Million
≈ $45.60 Million
0.192x -20.30%
2006-12-31 €191.80 Million
≈ $224.23 Million
€46.10 Million
≈ $53.90 Million
0.240x --

About Oriola-KD Oyj A

HE:OKDAV Finland Pharmaceutical Retailers
Market Cap
$64.02 Million
€54.76 Million EUR
Market Cap Rank
#20939 Global
#103 in Finland
Share Price
€1.02
Change (1 day)
+0.00%
52-Week Range
€1.02 - €1.02
All Time High
€3.40
About

Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed… Read more